BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//APPG for Prescribed Drug Dependence - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:APPG for Prescribed Drug Dependence
X-ORIGINAL-URL:https://prescribeddrug.org
X-WR-CALDESC:Events for APPG for Prescribed Drug Dependence
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20201027T093000
DTEND;TZID=Europe/Helsinki:20201027T170000
DTSTAMP:20260418T174212
CREATED:20200717T100411Z
LAST-MODIFIED:20240519T122030Z
UID:11106-1603791000-1603818000@prescribeddrug.org
SUMMARY:Chrodis Plus Online Conference on Chronic Diseases
DESCRIPTION:ON BEHALF OF JOINT ACTION CHRODIS PLUS\n WE WOULD LIKE TO THANK YOU FOR YOUR PARTICIPATION AT THE CONFERENCE\nKey conference materials will be made available soon here. \n[table id=30 /]\nPRESS RELEASE\nOver its 3-year lifespan\, the aim of CHRODIS PLUS Joint Action (2017-2020) was to support Member States in overcoming the burden of chronic diseases by promoting policies and practices that have proved successful in the past. Further refinement and EU cross-border sharing of these tested policies and good practices has been the core idea behind this pan-European project. \nCHRODIS PLUS has implemented 21 pilot projects aimed at testing tools and good practices for certain chronic diseases\, and held 17 policy dialogues (15 national and 2 EU-level ones). It has brought together over 50 partners from 21 European countries. \nAll good things come to an end: CHRODIS PLUS held its closing online conference on 27 October 2020. \nThis conference illustrated the impact that CHRODIS PLUS has had on public health systems across EU member states over the past 3 years. It focused on showing how the good practices\, models and tools implemented by the project can be tailored to various national and local settings across Europe. \nThe conference’s presentations and roundtable discussions were structured around the project’s key focus areas: \n\nHealth Promotion & Primary Prevention\nAn Integrated Multimorbidity Care Model\nFostering Quality Care for People with Chronic Diseases\nICT-based Patient Empowerment\nEmployment & Chronic Diseases
URL:https://prescribeddrug.org/event/chrodis-plus-online-conference-on-chronic-diseases/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20201002T113000
DTEND;TZID=Europe/Helsinki:20201002T130000
DTSTAMP:20260418T174212
CREATED:20200819T111755Z
LAST-MODIFIED:20200819T122632Z
UID:11361-1601638200-1601643600@prescribeddrug.org
SUMMARY:Closing the evidence-practice gap on NCDs: Translation\, transfer and sustainability for comprehensive responses across Europe
DESCRIPTION:The session is part of the online conference ‘EHFG 2020: Dancing with elephants: New partnerships for health\, democracy\, business’ organized by the European Health Forum Gastein. \n \nOn the surface\, the steps to closing the gap between research findings and existing clinical practice are simple: 1. Identifying good practice; 2. Piloting; 3. Scaling-up. However\, promising initiatives – and the big players overseeing them – often get stuck at the first step. At the same time\, mechanisms like crowdfunding and startups have proven to mark a shift from the few major players towards community driven initiatives\, often based on ideas and passion. \nThis session will showcase how ideas and passion on a small scale can be transferred to cross-national learning while respecting national interests\, and explore the success factors to piloting\, transferring and sustaining good practices that benefit patients affected by chronic disease. We will showcase outcomes of the CHRODIS+ Joint Action\, focused on supporting Member States in scaling up practices aimed at reducing the burden of non-communicable diseases\, and discuss how learnings on both the successes and barriers from the Joint Action can be taken forward to help health stakeholders achieve policy impact in the future. Join us to be guided through the potential dancing steps of ambitious partnerships in the battle against chronic disease!
URL:https://prescribeddrug.org/event/closing-the-evidence-practice-gap-on-ncds-translation-transfer-and-sustainability-for-comprehensive-responses-across-europe/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20200218T090000
DTEND;TZID=Europe/Helsinki:20200218T123000
DTSTAMP:20260418T174212
CREATED:20200220T084549Z
LAST-MODIFIED:20200220T084549Z
UID:10745-1582016400-1582029000@prescribeddrug.org
SUMMARY:Chrodis Plus Policy Dialogue in Hungary
DESCRIPTION:The Chrodis Plus policy dialogue held in Budapest\, Hungary on 18 February 2020 has addressed the role of AI and BI solutions in medical decision support solutions. \nNational screening programs are potentially the most profitable public services in the health system\, with the highest per-unit cost. There is a strong social interest in the efficient running of programs\, so it is vital to incorporate state-of-the-art IT solutions as widely as possible. During the dialogue\, participants looked at two options for information technology: \n\n Technology assessment and regulatory environment\n Artificial intelligence and deep learning algorithms\n\nArtificial intelligence solutions can play a primary role in evaluating the results\, supporting medical decision-making and improving the effectiveness of screening programs. Numerous publications are available that corroborate the diagnostic effectiveness of deep learning algorithms\, primarily in medical imaging\,  but also in other medical decision areas. During the dialogue\, we assessed which programs could be assisted by AI\, what the prerequisites are\, how we can create a training database that supports algorithm development\, and how we can build an IT infrastructure capable of serving a national program. \nThe medical application of artificial intelligence also raises new regulatory issues. There are many situations in which artificial intelligence decides whether a person’s condition requires medical attention. For example\, remote monitoring of patients with chronic illnesses\, where processing large amounts of data without computer support is unthinkable. Regulating the application of AI technology and clarifying liability issues give legislators tasks. AI also poses new challenges in technology assessment procedures. AI as a decision making support for medical staff can contribute to the detection of chronic diseases at an early stage\, thus alleviate national healthcare systems from the burden of treating acute chronic diseases. AI is based on extracting knowledge from massive pools of data\, which demands the creation of data pools at national or international level. This needs government interaction at three levels:  \n– IT infrastructure: sound IT systems collecting\, storing and distributing data \n– Process management: well designed patient pathways that allow an optimal access of patient to screening supported by AI \n– Legal regulations: a transparent legal background including data protection regulations\, a transparent distribution of access rights to data \n  \nDetailed report about the event will be added to this page by 18 March 2020. \n 
URL:https://prescribeddrug.org/event/chrodis-plus-policy-dialogue-in-hungary/
LOCATION:Budapest\, Budapest\, Hungary
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20191112T130000
DTEND;TZID=Europe/Helsinki:20191114T140000
DTSTAMP:20260418T174212
CREATED:20190807T121858Z
LAST-MODIFIED:20190912T132032Z
UID:10446-1573563600-1573740000@prescribeddrug.org
SUMMARY:European Patients' Forum Congress
DESCRIPTION:Congress programme\nCongress registration\nWe are happy to announce that on 12-14 November 2019 the European Patients’ Forum will hold the first ever European Congress on patient involvement. \nThis event will be driven by leading representatives of the patient community\, and patient experts\, in the capital of the European Union. \nThe event will also provide an exceptional opportunity for dialogue\, engagement with a wide range of health players who aspire to make patient involvement a reality. \nThis Congress is aimed at exchanging ideas and good practices in patient empowerment and involvement\, moving forward on the much-needed policy commitments in this area\, gaining a greater and genuine understanding of the wealth of expertise that patients bring to health systems’ design and strengthening\, and much more! \nStay tuned for programme details\, speakers updates and other highlights by subscribing to the Congress newsletter\, and take a look at the latest version of the programme here. \n 
URL:https://prescribeddrug.org/event/european-patients-forum-congress/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20191112T090000
DTEND;TZID=Europe/Helsinki:20191112T110000
DTSTAMP:20260418T174212
CREATED:20190912T133240Z
LAST-MODIFIED:20191211T113247Z
UID:10491-1573549200-1573556400@prescribeddrug.org
SUMMARY:EU Policy Dialogue on Employment and Chronic Conditions
DESCRIPTION:Click here to read the rationale and aims of this policy dialogue\nDownload the introductory presentation of the event\nAGENDA\nWelcome\nMassimiliano Salini\, MEP\n[embedyt] https://www.youtube.com/watch?v=5CE6gJ22eHU[/embedyt]\n\n\n\n\nChrodis Plus Joint Action \nRokas Navickas\, VULSK Lithuania\, Chrodis Plus Scientific Coordinator\n[embedyt] https://www.youtube.com/watch?v=RGY9ayxxc40[/embedyt]\n\n  \nEmployment and Chronic Conditions: a European Challenge\nThe Chrodis Plus Toolbox\nMatilde Leonardi\, FINCB Italy\, Chrodis Plus WP8 Leader\nJaana Lindstrom\, Eeva Rantala\, THL Finland\, Chrodis Plus WP8 Co-leader\n[embedyt] https://www.youtube.com/watch?v=xY3q1A0opX4[/embedyt]\n\n\n\n\n\nRound table\nAddressing the impact of chronic diseases in the employment sector.\nWhat are the practical steps for EU policy to support employment for people with chronic diseases?\nModerator: Clive Needle\, EuroHealthNet\, Brussels\nKatie Gallager\, European Patients Forum\, EPF\nRaymond Vanholder\, European Chronic Disease Alliance\, ECDA\nAlberto Lapi\, Accenture\, Representative of Enterprises\nSarah Cospey\, European Agency for Safety and Health at Work\, EU-OSHA\nAnna Ludwinek\, European Foundation for Improvement of Living &Working Conditions EUROFOUND\nMartin Jefflen\, Trade Union voice of professionals and managers\, EUROCADRES \n  \n\n\n\nWhy best practices delivered by Chrodis Plus are significant?\nClive Needle | EuroHealthNet\n\n[embedyt] https://www.youtube.com/watch?v=u28xyxv1t_0[/embedyt]\n\n\n\n\n\n\nExplaining the practical use and benefits of the Chrodis Plus Toolbox\nKatie Gallagher | European Patients Forum\n\n[embedyt] https://www.youtube.com/watch?v=SyqxWK9x5Rk[/embedyt]\n\n\n\n\n\n\nSummary\nThe increasing prevalence of chronic conditions in Europe’s working age population underlines the need for a European strategy towards inclusion\, integration and reintegration of employees in the workplace as well as towards the development of actions to support workers’ health and wellbeing. \nThe JA Chrodis Plus Policy Dialogue on employment and chronic conditions will aim to identify the practical steps for EU policy to support employment for people with chronic diseases and to address the impact of chronic diseases in the employment sector. \nEpidemiological transition and ageing across Europe is resulting in a rise of chronic diseases in the working population that will impact on the health and welfare sectors as well as an employment sector. This is a crucial issue for European and national policy makers\, patients\, NGOs\, academies\, and civil society which need legal\, social\, political and technical tools to face the challenge. Relevant stakeholders need to be encouraged to implement actions on the employment and chronic conditions at European and national level. The European Union has a significant role to play in supporting and encouraging national labour reforms\, sharing innovative ideas and helping to create successful policy frameworks. \nQuestions for the Round Table discussion \n\nWhat are the practical steps for EU policy to support employment for people with chronic diseases and to address the impact of chronic diseases in the employment sector?\nHow can the EU support health promotion and disease prevention in the workplace for people with or at risk for chronic conditions?\nCan policies and implementation of best practices tackle the employment sector as an area where care of people’s health should be improved?\nHow can EU Policy support the implementation of the TOOLBOX: Training Tool and Toolkit?\nHow can the Chrodis Plus Training Tool and Toolkit promote or support existing European policies on inclusion and work ability of people with chronic conditions?\n\n\n\nAims of the EU Policy Dialogue on Employment and Chronic Conditions: \n\n\n\nbring together EU stakeholders for a common understanding of the benefits of the workplace inclusion\, integration and reintegration of people with chronic conditions\,\npresent the Chrodis Plus Toolbox on Employment and Chronic Conditions developed within the EU Joint Action CHRODIS PLUS. This Toolbox includes a Training Tool for managers on workplace inclusion and work ability and a Toolkit for workplace adaptation\, health promotion and disease prevention. The TOOLBOX  will be freely available in different languages on the Chrodis website from April 2020.\n\nExpected outcomes:\n\nto draw attention to the effect that chronic conditions have in the work sector by adopting interventions and strategies that approach health in all sectors\,\nto encourage all relevant stakeholders to implement the Chrodis Plus Toolbox\n\n\nCHRODIS PLUS Work Package 8 on Employment and Chronic Conditions (https://prescribeddrug.org/08-employment/) involves 12 institutional partners from 10 different European countries and aims to: \n\nImplement good practices in the employment sector for people with chronic conditions: development of CHRODIS-PLUS Training tool for managers\nDevelop a CHRODIS-PLUS Toolkit for adaptation of the workplace for access\, prevention and maintenance of chronic conditions at the workplace\nDevelop a road map for health promotion and disease prevention (HPDP) in the workplace for people with chronic conditions including access to\, reintegration\, maintenance and stay at work tackling the employment sector as an area where care of people with chronic conditions should be improved\, by policies and implementation of best practices.\n\nOfficial language: English \nPicture gallery of the event \n[Best_Wordpress_Gallery id=”85″ gal_title=”WP8 EU Policy Dialogue”]
URL:https://prescribeddrug.org/event/eu-policy-dialogue-on-employment-and-chronic-conditions/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20190930T083000
DTEND;TZID=Europe/Helsinki:20190930T180000
DTSTAMP:20260418T174212
CREATED:20190924T133203Z
LAST-MODIFIED:20191016T120409Z
UID:10541-1569832200-1569866400@prescribeddrug.org
SUMMARY:EU Health Programme High Level Conference
DESCRIPTION:This high level conference highlighted the results of the current and previous EU Health Programmes and presented the new approach in the future Multiannual Financial Framework for 2021-2027. \nThe event was hosted by Vytenis Andriukaitis\, European Commissioner for Health\, and is organised by the Consumers\, Health\, Agriculture and Food Executive Agency with support by the European Commission Directorate-General for Health and Food Safety. \nDate: Monday\, 30 September 2019 \nVenue: The Square\, Mont des Arts\, Brussels\, Belgium \nTarget audience:beneficiaries of the health programme\, policy-makers\, researchers\, health professionals\, representatives of intergovernmental organisations\, NGO’s; civil society organisations \nAgenda is available under the following link: \nhttps://ec.europa.eu/chafea/health/newsroom/news/18032019/index_en.htm \nOur scientific coordinator Dr. Rokas Navickas presented the activities currenty carried out in Joint Action Chrodis+ along with the preliminary results and impact. His presentation is available here: \nRokas Navickas presentation at EU Health Programme Conference
URL:https://prescribeddrug.org/event/eu-health-programme-high-level-conference/
LOCATION:Brussels – Belgium\, Mont des Arts\, Brussels\, 1000\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20190919T140000
DTEND;TZID=Europe/Helsinki:20190919T150000
DTSTAMP:20260418T174212
CREATED:20190802T115413Z
LAST-MODIFIED:20190926T073130Z
UID:10440-1568901600-1568905200@prescribeddrug.org
SUMMARY:Open webinar: Employment and Chronic Conditions  in Europe - Facing the challenge
DESCRIPTION:View Agenda \nThursday 19 September 2019\, 14.00 – 15.00 CET\, Brussels time \nThe webinar is publicly available in the Public Health website: https://ec.europa.eu/health/policies/videos_en#anchor0 under the title ’19 September 2019 Second Webinar of the CHRODIS PLUS joint action – Employment and chronic conditions in Europe‘  \nDownload recording link: https://ecwacs.webex.com/ecwacs/lsr.php?RCID=530565c03288f3db79841ccf6feeb1f3    \n\nWebinar invitation\nThe “Chronic Diseases and Employment” work package of the CHRODIS PLUS project in collaboration with EU Health Policy Platform invites you to a webinar on “Employment and Chronic Conditions in Europe – Facing the challenge” on 19 September 2019 from 14.00 to 15.00 p.m. (CET). \nThis webinar will present the answers provided by Chrodis Plus to the European challenge on chronic conditions in the work sector. It provides information about the birth of the CHRODIS PLUS Training Tool\, which has been developed to help employers understand the benefits of the workplace inclusion\, integration and reintegration of people suffering from chronic diseases. Managers are encouraged to implement the Training Tool to evaluate inclusiveness and work ability of their teams so as to create facilitating environments for reaching desirable organizational outcomes: productivity\, job satisfaction of all employees\, and organizational commitment. Thus\, it gives a general heads up on the importance and impact of these themes in the society of today. \nThe webinar will demonstrate the importance of informing managers\, HR departments and employers regarding the capacities of people with chronic conditions to continue working\, return to work\, maintenance of work\, fighting stigma and inappropriate behaviors when there is disclosure of a chronic condition. \n\n\n\n\n\n\n\nWe encourage you to share this information with your network and promote the link further.
URL:https://prescribeddrug.org/event/employment-and-chronic-conditions-in-europe-facing-the-challenge-open-webinar/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190621
DTEND;VALUE=DATE:20190622
DTSTAMP:20260418T174212
CREATED:20190708T150413Z
LAST-MODIFIED:20190708T150413Z
UID:10436-1561075200-1561161599@prescribeddrug.org
SUMMARY:Visit to Spanish implementation site in Zaragoza
DESCRIPTION:On 21th June 2019\, Carmen Rodriguez-Blazquez and Maria João Forjaz (ISCIII) held a visit to Aragon Health Sciences Institute (IACS)\, in Zaragoza\, Spain. The primary care centre Actur-Norte and the Chronic Care Unit at Royo Villanova Hospital were both visited. The implementation team presented the three main strategies of the practice: training of professionals in multimorbidity (eMultiPAP)\, integrating complex chronic patients components (comprehensive assessment\, virtual interconsultation\, and electronic health records)\, and community care actions (health needs identification and resources map). The meeting closed with a debate on the facilitators\, barriers and benefits of the program.  \n \n 
URL:https://prescribeddrug.org/event/visit-to-spanish-implementation-site-in-zaragoza/
LOCATION:Aragon Health Sciences Institute (IACS)\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190610
DTEND;VALUE=DATE:20190611
DTSTAMP:20260418T174212
CREATED:20190617T074145Z
LAST-MODIFIED:20190617T074145Z
UID:10330-1560124800-1560211199@prescribeddrug.org
SUMMARY:Spanish Policy Dialogue in Madrid
DESCRIPTION:  \nOn the 10th of June 2019 the Spanish Policy Dialogue took place in Madrid\, Spain. Please find detailed information and pictures about the event below. \n  \nTitle of the policy dialogue:  \nALTERNATIV35. Health Impact Assessment. Alternatives for effective implementation of Article 35 of the Spanish Public Health Act 33/2011 \n  \nExtended explanation:  \nThis policy dialogue focused on Health Impact Assessment (HIA). HIA is a useful tool for evaluating health policies but also for increasing awareness about the Health in All Policies approach and for boosting inter-sectoral collaboration. \nThe goal of this policy dialogue was to consider the integration of HIA into environmental projects and policies\, thus enhancing collaboration between the Ministry of Health\, Consumer Affairs and Social Welfare and the Ministry for the Ecological Transition. \n  \nGeneral Intro to CHRODIS PLUS Policy Dialogues: \nThis is the summary of one of the 17 policy dialogues organised under the Chrodis PLUS Joint Action. For a summary of all Policy dialogues please visit the chrodis.eu/policy-dialogues webpage. These dialogues are to serve as inspiration for policy makers in other countries who are seeking good practices to consider when planning their own national policy dialogue processes. \n  \nProblem identification: \nThe specific question for this policy dialogue was to elucidate which would be the most effective way to implement in practice HIA in all Spanish Regions and therefore developing Article 35 of the Spanish Public Health Act 33/2011 that mandates that selected regulations\, plans\, programmes and interventions with an impact on health are subjected to HIA. \n  \nWhat is the primary reason for choosing this topic in your country? \nArticle 35 of the Spanish Public Health Act 33/2011 does not specify which policies are eligible for HIA. Additionally\, underway of finished policies are not eligible for HIA. However\, their evaluation would provide useful information to policy makers. \nFurthermore\, the Act does not mandate to specifically use HIA methodology (or whether other methodologies are eligible).   HIA might be useful for evaluating some policies but others are not subjected to HIA. Other useful methodologies should be taken into account. \nEnvironmental Impact Assessment (EIA) was already underway and mandatory. A debate among experts about integrating HIA into EIA as an effective solution is underway and some Spanish Regions are already implementing this approach. \n  \nThe policy dialogue process: \nA high level meeting with the participation of the Secretaries of both Ministries took place. The main dialogue was held between the General Director of Public Health and the General Director of Environmental Quality. After introductions by the representative from EuroHealthNet\, and the other two keynote speakers from the General Directorate of Public Health\, Quality and Innovation\, the dialogue answered to the following questions: \n·       Health and Environment are intimately related factors. What is your perception of such relationship? \n·       How can we improve the integration of health into environmental policies and into EIA? \n·       What is your opinion of the recommendations for HIA included in the document “Proposals towards effective Health Impact Assessment”? Which specific measures would you prioritize to effectively integrate health into environmental policies? \nAfter the discussion it was agreed to accept the recommendations of the document “Proposals towards effective Health Impact Assessment” and to create an Inter-Departmental working group to tackle the above mentioned topics. \n  \nKey stakeholders: \nPolicy makers:  \nBoth Secretaries introduced the policy dialogue to the audience and the general directors held the dialogue \nHugo Morán. Secretary of State of Environment\, MITECO. \nFaustino Blanco. General Secretary of Health and Consumer Affairs. MSCBS. \nFrancisco Javier Cachón. General Director of Biodiversity and Environmental Quality. MITECO \nPilar Aparicio. General Director of Public Health\, Quality and Innovation. MSCBS. \nKeynote Speakers: \nLina Papartyte. EuroHealthNet. \nCovadonga Caballo. Deputy Director of Environmental Health and Occupational Health. MSCBS. \nPilar Campos. Deputy Director of Health Promotion and Public Health Surveillance. MSCBS. \nModerator: \nAntonio Sarría. Director of the National School of Health. Carlos III Health Institute. \nRapporteur: \nIñaki Imaz. Agency for Healthcare Technology Evaluation. Carlos III Health Institute. \nMinute takers: \nJara Cubillo. Health Promotion Department. MSCBS \nAlberto Martin-Pérez. Health Promotion Department. MSCBS \nAttendees: \nIsmael Aznar. Director of Cabinet of the State Secretary of Environment. MITECO \nFrancisco Muñoz. Advisor of Cabinet of the State Secretary of Environment. MITECO \nJulio Bruno. Head of Technical Cabinet of the General Secretary of Health and Consumer Affairs. MSCBS. \nEugenio Domínguez. Deputy Director of Environmental Assessment. MITECO \nMaj Britt Larka. Deputy Director of Air Quality and Industrial Environment. MITECO \nYolanda Agra. Deputy Director of Quality and Innovation. MSCBS. \nFrancisco Vargas\, Margarita Palau\, Santiago González. Subdirectorate General of Environmental Health and Occupational Health. MSCBS \nMaría Terol\, Claudia Ruiz-Huerta. Subdirectorate General of Health Promotion and Public Health Surveillance. MSCBS. \nCarmen Arias. General Subidirectorate of Quality and Innovation.  MSCBS. \n  \nHow the EU supported this dialogue? \nEuroHealthNet participated in the policy dialogue introducing the main framework of Chrodis PLUS to participants and highlighting already conducted policy dialogues that had focused on intersectoral action for inspiration. \n  \nPhotos from the event \n[Best_Wordpress_Gallery id=”81″ gal_title=”Spanish PD”]\n 
URL:https://prescribeddrug.org/event/spanish-policy-dialogue-in-madrid/
LOCATION:Madrid\, Madrid\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190607
DTEND;VALUE=DATE:20190608
DTSTAMP:20260418T174212
CREATED:20190708T150149Z
LAST-MODIFIED:20190708T150149Z
UID:10433-1559865600-1559951999@prescribeddrug.org
SUMMARY:Visit to Spanish implementation site in Seville
DESCRIPTION:On June 7th 2019\, Carmen Rodriguez-Blazquez (ISCIII) and Elisa Poses-Ferrer (AQuAS) visited San Jose de la Rinconada primary care center in Seville. Visitors received information on the Andalusian Comprehensive Healthcare Plan for Patients with Chronic Diseases (which includes training activities to health professionals)\, and the way Individualized care plans for multimorbid patients are completed within the corporate electronic health record (Diraya)\, and shared with patients interviewed by healthcare professionals. Participants also had the opportunity to discuss the benefits\, experienced barriers and facilitators of the pilot action with the local implementers.
URL:https://prescribeddrug.org/event/visit-to-spanish-implementation-site-in-seville/
LOCATION:San Jose de la Rinconada primry care centre in Seville\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190604
DTEND;VALUE=DATE:20190606
DTSTAMP:20260418T174212
CREATED:20190604T081248Z
LAST-MODIFIED:20190611T135635Z
UID:10130-1559606400-1559779199@prescribeddrug.org
SUMMARY:2nd CHRODIS PLUS Governing Board meeting
DESCRIPTION:[Best_Wordpress_Gallery id=”78″ gal_title=”Malta Group Photo”]\nMembers of the Governing Board and the Executive Board of the Joint Action \nAgenda of the meeting \nObjectives of the meeting\n\nto get accounted with the latest updates from the biggest JA tackling the burden non-communicable diseases and review innovative practice examples that are implemented by concrete pilot site in the different CHRODIS PLUS work packages;\nto discuss how Prevention and Management of Non-Communicable Diseases post 2020 and potential EU funding strategy could be aligned with the activities at the national level;\nto take further steps in creation of common vision and high level response to the burden of non-communicable diseases;\nto discuss the possible scenario of the Steering Group on Promotion and Prevention (SGPP) “structured dialogue” with CHRODIS PLUS on the sustainability and future;\nto give feedback on the structure and content of the survey (for SGPP members)\, as well as to discuss on how to gain the maximum results from the survey optimising the efforts;\nto visit a Pilot site at ST. MICHAEL SCHOOL\, KINDERGARTEN in Malta and get sight of ToyBox good practice implementation in Malta;\n\nKey presentations\n\nKey objectives of CHRODIS PLUS\, Rokas Navickas. PRESENTATION\nConnect the dots in Health Promotion and Disease Prevention. Adaptation and implementation of ToyBox good practice in Malta\, Roberta Zarb. PRESENTATION\nFrom evidence to practice: Integrated Multimorbidity Care Model. The potential roll out in Lithuania health care system\, Elena Jureviciene PRESENTATION and Gitana Ratkiene. PRESENTATION\nHow to improve the quality of care for people with chronic diseases? – The Quality Criteria and Recommendations tool. The potential for pilot site in Slovenia to be spread system wide\, Denis Opresnik and Jelka Zaletel. PRESENTATION\nEmployment and NCDs: health in all sectors. Implementing prevention\, inclusion\, maintenance\, return to work actions\, Matilde Leonardi. PRESENTATION\nOECD support: Cost-effectiveness and transferability of CHRODIS PLUS pilots. OECD\, Dr Michele Cecchini. PRESENTATION\nPrevention and Management of NCDs: the potential of EU plans post 2020. DG SANTÉ\, Nicoline Tamsma. PRESENTATION\nEU funding review\, Andrew Barnfield (TBD). PRESENTATION\nIntegration in National Policies and Sustainability. Consensus statement. Is there an opportunity for GB members to act? WP4\, Dr.Giovanni Nicoletti. PRESENTATION\n\nPictures on the Governing Board meeting\n[Best_Wordpress_Gallery id=”57″ gal_title=”Governing Board meeting in Malta”]\nPictures on the site visit to a local kindergarden\nAt the kindergarten of the ST. MICHAEL SCHOOL \, elements of the ToyBox best practices were implemented as part of the CHRODIS PLUS Work Package 5 activities focusing on health promotion and prevention. To read more about the ToyBox model click here. \n[Best_Wordpress_Gallery id=”58″ gal_title=”Kindergarden visit in Malta”]
URL:https://prescribeddrug.org/event/2nd-governing-board-meeting-2/
LOCATION:Malta\, Triq Wied Ghollieqa\, San Ġwann\, Valetta\, Malta
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20190514T140000
DTEND;TZID=Europe/Helsinki:20190515T140000
DTSTAMP:20260418T174212
CREATED:20190409T105645Z
LAST-MODIFIED:20190628T085818Z
UID:9342-1557842400-1557928800@prescribeddrug.org
SUMMARY:CHRODIS PLUS Budapest Conference 14-15 May 2019
DESCRIPTION:On behalf of Joint Action CHRODIS+ we would like to thank you for your participation at the Conference\n \nThe event was co-funded by the European Health Programme. \n[vc_row][vc_column width=”1/2″][vc_column_text css=”.vc_custom_1526296768304{margin-bottom: 0px !important;}”]\nMiklós Szócska\nSemmelweis University of Hungary\nFormer Hungarian Minister of Health\n \n[/vc_column_text][vc_column_text css=”.vc_custom_1531215567407{margin-bottom: 0px !important;}”]\nAntonio Sarria Santamera\, Chrodis Plus Coordinator\n \n  \n[/vc_column_text][/vc_column]\n[vc_column width=”1/2″][vc_column_text css=”.vc_custom_1526295285903{margin-bottom: 0px !important;}”]\nWojciech Kalamarz\nHead of Unit for Health Determinants and International Relations DG Sante\, European Commission\n \n[/vc_column_text][vc_column_text css=”.vc_custom_1531215620007{margin-bottom: 0px !important;}”]\nRokas Navickas\, Chrodis Plus Scientific Coordinator\n \n[/vc_column_text][/vc_column][/vc_row]\n[vc_column width=”1/2″][vc_column_text css=”.vc_custom_1526295285903{margin-bottom: 0px !important;}”]\nRenata Pap\nHungarian Ministry of Human Capacities\n \n[/vc_column_text][/vc_column]\n[vc_column width=”1/2″][vc_column_text css=”.vc_custom_1526295285903{margin-bottom: 0px !important;}”]\nMatilde Leonardi\, The Foundation of the Carlo Besta Neurological Institute\, Italy\n \n[/vc_column_text][/vc_column]\n[vc_column width=”1/2″][vc_column_text css=”.vc_custom_1526295285903{margin-bottom: 0px !important;}”]\nAndrew Barnfield\, EuroHealthNet and Nella Savolainen\, National Institute for Health and Welfare of Finland\n \n[/vc_column_text][/vc_column]\n[vc_column width=”1/2″][vc_column_text css=”.vc_custom_1526295285903{margin-bottom: 0px !important;}”]\nInaki-Imaz Iglesia\nInstitute of Health Carlos III\, Spain\n \n[/vc_column_text][/vc_column]\n[vc_column width=”1/2″][vc_column_text css=”.vc_custom_1526295285903{margin-bottom: 0px !important;}”]\nJelka Zaletel\nNational Institute of Public Health of Slovenia\n \n[/vc_column_text][/vc_column]\n[vc_column width=”1/2″][vc_column_text css=”.vc_custom_1526295285903{margin-bottom: 0px !important;}”]\nEsteban de Manuel\nKronikgune Research Centre on Chronic Diseases\,Spain\n \n[/vc_column_text][/vc_column]\n[vc_column width=”1/2″][vc_column_text css=”.vc_custom_1526295285903{margin-bottom: 0px !important;}”]\nGraziano Onder\nCatholic University of the Sacred Heart\, Italy\n \n[/vc_column_text][/vc_column]\n[vc_column width=”1/2″][vc_column_text css=”.vc_custom_1526295285903{margin-bottom: 0px !important;}”]\n[mk_circle_image src=”https://prescribeddrug.org/wp-content/uploads/2014/09/WP1-PICT01.jpg” image_diameter=”280″]\n[/vc_column]\n[vc_separator][vc_column_text css=”.vc_custom_1526999465190{margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;padding-top: 5px !important;padding-right: 10px !important;padding-bottom: 10px !important;padding-left: 10px !important;background-color: #ffffff !important;}”]\n\n[Best_Wordpress_Gallery id=”52″ gal_title=”Budapest Conference”]\n[table id=21 /]\n  \n[table id=22 /]\nAchieving long-term goals\, such as staying healthy\, requires the ability to maintain healthy lifestyle and the ability to resist temptations over and over again. Eeva Rantala gave us the insight on how to be the choice architect of our own lives. The bonus presentation is available here. \n[accordions id=”9552″]\n  \n\n  \n  \n\nClick here to read the CHRODIS PLUS Budapest Conference Newsletter \n\nPress Release – please share\nThe Budapest Conference of the CHRODIS PLUS Joint Action \n14-15 May 2019 \nBudapest\, Hungary \nThe CHRODIS PLUS Joint Action of the European Union (2017-2020)\, has brought together over 50 project partner institutions\, representing 21 European countries\, to collaborate on and implement 21 pilot projects\, to test public health models and tools\, and to organise 15 national and 2 EU level policy dialogues. The aim is to generate practical and policy level lessons to support Member States in tackling the burden of chronic diseases. During its 36 months of operation\, this project contributes to the reduction of this burden by promoting the implementation of policies and practices that have been already successfully tested. The further refinement and cross-border sharing of these tested policies and good practices across EU countries is the core idea behind this action. \nThe CHRODIS PLUS Budapest Conference on 14-15 May has been one of the key events in this project where over 180 chronic disease experts arrived from 26 countries to discuss and provide feedback on the real-life experiences project partners have gained during the initiative’s first 20 months. This conference demonstrated the impact that CHRODIS PLUS has on public health systems across EU Member States with a special emphasis on proving that the good practices\, models and tools that the project implements can be tailored to various national and local settings across Europe. The conference’s presentations and roundtable discussions were structured around the project’s key focus areas: Health Promotion & Primary Prevention\, an Integrated Multimorbidity Care Model\, Fostering Quality Care for People with Chronic Diseases\, ICT-based Patient Empowerment\, and Employment & Chronic Diseases.   \nMore information about our work is available at the CHRODIS PLUS website: https://prescribeddrug.org/our-work/ \n  \n \n 
URL:https://prescribeddrug.org/event/budapest-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20190514T083000
DTEND;TZID=Europe/Helsinki:20190514T133000
DTSTAMP:20260418T174212
CREATED:20190409T110045Z
LAST-MODIFIED:20190607T120439Z
UID:9345-1557822600-1557840600@prescribeddrug.org
SUMMARY:CHRODIS+ Budapest General Assembly May 14th 2019
DESCRIPTION:GENERAL ASSEMBLY OF JOINT ACTION CHRODIS PLUS \n14 May – Tuesday 08.30 – 14.00 \nLocation: Hotel Benczur\, Budapest\, Benczúr street 35\, 1068 Hungary \nOn behalf of Joint Action CHRODIS+ we would like to thank all partners for taking part at the General Assembly. \nDown below you may find the presentations as well as the picture gallieries from the event. \nThe general assembly was made possible thanks to our work package leaders and their team active involvement. \nThank you all for participation! \n  \n \n[Best_Wordpress_Gallery id=”43″ gal_title=”Pre event general photos”]\nAgenda \n  \n[table id=20 /]\nHealthy lifestyle is the foundation of both prevention and tratment of non-communicable diseases. Many of us know this and strive for leading a healthy life\, yet struggle translating good intention into action. Eeva Rantala explained it all in her bonus presentation during General Assembly. The presentation is available here. \n  \n 
URL:https://prescribeddrug.org/event/budapest-general-assembly/
LOCATION:Hotel Benczur\, Benczur street 35\, Budapest\, 1068\, Hungary
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20190513T100000
DTEND;TZID=Europe/Helsinki:20190513T180000
DTSTAMP:20260418T174212
CREATED:20190502T065340Z
LAST-MODIFIED:20190524T121239Z
UID:9558-1557741600-1557770400@prescribeddrug.org
SUMMARY:CHRODIS+ pre-Conference workshops - 13 May
DESCRIPTION:LINK TO SOCIAL EVENT – BOAT RIDE\nEvents for CHRODIS PLUS partners: beneficiaries\, implementing partners\, collaborating and associated partners \nLocation: Hotel Benczur\, Budapest\, Benczúr street 35\, 1068 Hungary\n  \n[Best_Wordpress_Gallery id=”42″ gal_title=”Pre event general photos”]\nWork Package 5 workshops\n[Best_Wordpress_Gallery id=”45″ gal_title=”Workshop WP5 May 13″]\n[Best_Wordpress_Gallery id=”54″ gal_title=”Workshop WP5 afternoon session May 13″]\n  \nWork Package 6 workshop\n[Best_Wordpress_Gallery id=”46″ gal_title=”Workshop WP6 May 13″]\nWork Package 7 workshop\n[Best_Wordpress_Gallery id=”47″ gal_title=”Workshop WP7 May 13″]\nWork Package 8 workshop\n[Best_Wordpress_Gallery id=”48″ gal_title=”Workshop WP8 May 13″]\n  \n[table id=23 /]\n  \nLink to CHRODIS PLUS General Assembly: 14 May 2019 @ 08:30 – 13:30 \nLink to CHRODIS PLUS Conference: TUESDAY 14TH MAY 14.00 – 19.30 AND WEDNESDAY 15TH MAY 9.00-13.00 \n  \n \n[Best_Wordpress_Gallery id=”35″ gal_title=”Budapest event May 13th”]
URL:https://prescribeddrug.org/event/chrodis-pre-conference-workshops-13-may/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190409
DTEND;VALUE=DATE:20190411
DTSTAMP:20260418T174212
CREATED:20190404T073115Z
LAST-MODIFIED:20190414T134158Z
UID:9291-1554768000-1554940799@prescribeddrug.org
SUMMARY:Site visit in Thessaloniki\, Greece
DESCRIPTION:This workshop is to evaluate internally the implementation activity of the Greek partners involved in CHRODIS PLUS. This workshop offers an opportunity to the partners to invite policy makers\, polititians andvpatients to discuss the value of this project and to build a strategy to sustain the project results after the CHRODIS PLUS project. \nA site visit by Work Package 7 Leaders to Thessaloniki \nDate: 9-10 April 2019 \nClick here to see the agenda of this event. \n \nSome workshop participants from left to right: \n\nSavopoulos Christos\, Professor of Internal Medicine\, Aristotle University of Thessaloniki\nChatzidimou Maria\, Vice-President of the Medical Association of Thessaloniki\nKokkoris Panagiotis\, Former General Secretary of Ministry of Labour\, Social Security and Social Solidarity\nMaria Antoniou\, Member of the Greek Parliament\nHatzitolios I. Apostolos\, Professor of Internal Medicine\, Aristotle University of Thessaloniki\n\n  \n[Best_Wordpress_Gallery id=”28″ gal_title=”WP7 Thessaloniki Workshop”]
URL:https://prescribeddrug.org/event/site-visit-in-thessaloniki-greece/
LOCATION:Thessaloniki\, Monastiriou Street 305\, Thessaloniki\, 54627\, Greece
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20190326T083000
DTEND;TZID=Europe/Helsinki:20190326T170000
DTSTAMP:20260418T174212
CREATED:20190409T111541Z
LAST-MODIFIED:20190423T103125Z
UID:9349-1553589000-1553619600@prescribeddrug.org
SUMMARY:Study visit in Zagreb\, Croatia
DESCRIPTION:The study visit in Zagreb presented the work of Croatian Institute of Public Health in the field of diabetes registries. \nWell established electronic patient registries improve quality indicators of diabetes control at population level due to better insights in patients’ health status\, improved health care delivery and better patient complience as well as continuous organisational improvement within and between involved health care providers. Specific aim of using the tool of Quality Criteria Recommenations in this implementation project is to increase use of diabetes control check-list as a minimum data set within diabetes registry. \nThe agenda of the meeting is available here: agenda_study-visit-croatia  \nAGENDA OF THE STUDY VISIT IN CROATIA \n8.30 – 9.00 Registration and coffee \n9.00 – 9.15  Welcome and introduction to the aims of the study visit \n9.15 – 9.45  What is CHRODIS+ and why are Pilot Actions needed (WP7 leaders Marina Maggini and Jelka Zaletel) \n9.45 – 10.45 Background of the Croatian Pilot Local Implementation Working Group (LIWG) presents Key performance indicators of the Pilot Action \n– Discussion and Q&A \n10.45 – 11.00  Coffee break \n11.00 – 12.00 Description of the Croatian Pilot \n– LIWG presents assessment of the Pilot Action implementation with respect to the criteria on patient involvement and to the indicators as proposed by EPF \n– Debate on key performance indicators with other participants from JA CHRODIS+ \n12.00 – 12.45  How to increase the pilot action sustainability and acalability with an aim to identify actions that would increase patient participation \n13.45 – 14.15  LIWG presents assesment of the Pilot Action implementation with respect to the criteria on scalability and sustainability\, building also on the result of first part of the study visit day \n14.15 – 16.15  Debate with other participants from JA CHRODIS+ with an aim to identify actions that would increase scalability and sustainability of the practice \n15.00 – 15.15 Coffee break \n16.15 – 17.00 Summary of the next steps\, lessons learnt\, feedback to WP7 leaders and European Patient Forum \nDownunder\, you can view the list of presentations: \nMarina Maggini and Jelka Zaletel – CHRODIS PLUS Work Package 7 Intro \nTamara Poljican – Croatian Pilot Description  \nDunja Skoko Poljak – Croatian Pilot from Ministry of Health Perspective  \nTatjana Bekic – Croatian Pilot from National Health Institute Perspective \nIvan Pristas – CroDiab registry  \nVjekoslava Amerl Saric and Valerija Bralic Lang – Panels – Tool for Diabetes Mellitus \nDomina Vusio – Baseline Analysis of Indicators \nMarko Brkic – Key Performace Indicators \nMarija Svajda – Sustainability and Scalability \nBrowse our picture gallery down below. \n[Best_Wordpress_Gallery id=”31″ gal_title=”Zagreb Study Visit”]\n 
URL:https://prescribeddrug.org/event/study-visit-in-zagreb-croatia/
LOCATION:Croatian Institue of Public Health\, Rockefellerova 12\, Zagreb\, Croatia (Local Name: Hrvatska)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20190315T093000
DTEND;TZID=Europe/Helsinki:20190315T103000
DTSTAMP:20260418T174212
CREATED:20190212T150726Z
LAST-MODIFIED:20190416T081156Z
UID:9171-1552642200-1552645800@prescribeddrug.org
SUMMARY:Webinar on "Health Promotion and Primary Prevention in 21 European Countries. A report prepared by the CHRODIS PLUS Joint Action."
DESCRIPTION:Webinar: “Health Promotion and Primary Prevention in 21 European Countries. A Comparative Overview of Key Policies\, Approaches\, Examples of Good Practice\, and Gaps and Needs. A report prepared by the CHRODIS PLUS joint action” takes place. \nDate: Friday 15 March 2019 from 09.30 to 10.30 CET Brussels time. \nWebinar was free and open to the public. A total of 53 participants attended this online webinar.  \nThe webinar is uploaded here: ec.europa.eu/health/sites/health/files/policies/videos/20190315_en.mp4 (during the month after the event a total of 553 personss viewed this link) \nLink to download: ecwacs.webex.com/ecwacs/lsr.php?RCID=4fd0e5416308790ae71e5a0593849bb7 \n  \nAgenda: \n            9.30 – 9.35        Welcome/Introductory remarks \nEuropean Commission\, DG SANTE \n            9:35 – 10:05      Presentation of the report \nAndrew Barnfield\, Coordinator\, Practice Platform\, EuroHealthNet\, Nella Savolainen\, Senior Specialist\, Welfare and Health Promotion Unit\, National Institute for Health and Welfare\, Finland \n            10:05 – 10:30    Questions from the participants and discussion
URL:https://prescribeddrug.org/event/webinar-on-health-promotion-and-primary-prevention-in-21-european-countries-a-report-prepared-by-the-chrodis-plus-joint-action/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190228
DTEND;VALUE=DATE:20190301
DTSTAMP:20260418T174212
CREATED:20190204T183050Z
LAST-MODIFIED:20190625T072308Z
UID:9089-1551312000-1551398399@prescribeddrug.org
SUMMARY:Expert meeting WP6-WP8 on "Employment in the multi-morbidity care model for people with chronic conditions"
DESCRIPTION:This expert meeting was organized in a collaboration between WP6 and WP8. \nObjectives of the event\n\nto address the problems of chronic patients with multi-morbidity\,\nto define how the employment might impact on the care process of these patients\, and\nto make aware the employment sector of their situation.\n\nMillions of European with non-communicable diseases will benefit from a more holistic biopsychosocial\, inclusive approach aiming to achieve the prevention of disability due to non-communicable diseases. \nThe output of this expert meeting has been the production of a document useful to the introduction of employment into the Multimorbidity Care Model so as to innovate care and pathways of chronic patients. \nFinal report on Employment in the Multimorbidity Care Model\nFinal Report on Employment in the Multimorbidity Care Model \nAppendix-1 List of Participants \nAppendix-2 Review type of interventions for reintegration of people with chronic diseases \nAppendix-3 Agenda \nAppendix-4 Chrodis background expert meeting \nAppendix-5 \nWorkshop presentations\nEmployment and persons with chronic diseases: an European key issue – Presentation\nDr. Matilde Leonardi\, Leader WP8\, FINCB Italy \nThe Multi-morbidity care model – Presentation\nDr. Rokas Navickas\, co-leader WP6\, VULSK Lithuania \nHow can working environment support employees with chronic diseases to adopt and maintain healthy lifestyles? – Presentation\nMs Eeva Rantala\, THL and VTT\, Finland \nEmployment and Chronic Disease: State of the art and work ability – Presentation\nDr. Fabiola Silvaggi\, FINCB Italy and Dr. Davide Vetrano\, UCSC Italy \nThe Multi-morbidity care model: Components – Presentation\nDr. Graziano Onder\, Leader WP6\, UCSC Italy \n[Best_Wordpress_Gallery id=”26″ gal_title=”Event_Rome_28 Feb 2019″]\n \n
URL:https://prescribeddrug.org/event/employment-in-the-multi-morbidity-care-model-for-people-with-chronic-conditions-wp8-wp6-expert-meeting/
LOCATION:Rome\, Largo Agostino Gemelli 8\, Rome\, Italy
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190130
DTEND;VALUE=DATE:20190131
DTSTAMP:20260418T174212
CREATED:20190208T171053Z
LAST-MODIFIED:20190208T171252Z
UID:9160-1548806400-1548892799@prescribeddrug.org
SUMMARY:Policy dialogue in Portugal on the Advertisement of Food and Beverages to Children
DESCRIPTION:A Policy Dialogue was held\, on the 30th of January\, at the Directorate-General of Health of Portugal. This meeting was focused on the Advertisement of Food and Beverages to Children. The main objective of this Policy Dialogue was to gather a group of national stakeholders\, in order to find ways to tackle this issue at a national level. \n\nIn this Policy Dialogue it was possible to shed a light on what each entity has done regarding this issue; to get to know what areas each entity considers more relevant\, within this issue and to discuss the most effective way of regulation – regulation vs. self-regulation. \n\nThere was also an identification of the main barriers regarding the regulation of Advertisement of Food and Beverages to Children. Additionally\, each entity stated their availability to develop new actions to tackle this issue in an intersectoral way. Afterwards\, there was a debate to define a strategy towards the conclusion of the legislative process on the Portuguese Advertising Code that is already ongoing.  \nThe Portuguese policy dialogue fits neatly with the Chrodis+ aim of adopting health promotion and primary prevention strategies as the best way to reduce the burden of chronic diseases. In this case it is through improving the environment that children and young people grow up in by maximising their opportunities to live long\, healthy lives by focussing on health dietary practices.\nAll entities present in this Policy Dialogue were directly or indirectly working on issues related to this subject. In general\, all entities agree with self-regulation but consider that it should coexist with regulation. It was said that the role of Health Literacy may be preponderant in changing behavior amongst children\, young people and families. Regarding perceived barriers\, digital media brings new challenges for the regulation of advertised content. Furthermore\, the measures to be applied must focus not only on the media and digital platforms\, but also on actions that attract children and young people\, such as festivals\, merchandising\, sporting events\, among others. It will be important to use digital influencers as partners for promoting healthier food choices and the “counter advertising” method may be a very important debunk to demystify myths about traditional advertising. \n\nThe next steps for Portugal will be to create a working group with the main stakeholders for the conclusion of the alteration of the Portuguese Advertising Code; and\, regarding communication\, to define several actions of Health Literacy for children\, youth and families\, through positive messages. \n[Best_Wordpress_Gallery id=”24″ gal_title=”Portugal Policy Dialogue_30 Jan 2019″]
URL:https://prescribeddrug.org/event/policy-dialogue-in-portugal-on-the-advertisement-of-food-and-beverages-to-children/
LOCATION:Lisbon – Portugal\, Lisbon\, Portugal
CATEGORIES:Policy Dialogue
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181203
DTEND;VALUE=DATE:20181205
DTSTAMP:20260418T174212
CREATED:20190121T095331Z
LAST-MODIFIED:20190207T163008Z
UID:8982-1543795200-1543967999@prescribeddrug.org
SUMMARY:Work package 7 workshop on interim follow-up
DESCRIPTION:Focus of the event: Ensuring that implementation projects meet patients’ expectations\, empower the target population and train to promote empowerment \nEvent organised by the European Patients’ Forum \nThe workshop took place on December 3rd – 4th 2018 in Belgrade\, Serbia \nObjective of this workshop was to set standardized pathways for the implementers of the Quality Criteria Recommendations Tool and to prepare them to successfully run the study visits that will take place in 5 implementing countries in 2019. Study visits are an important step in the implementation process. During the workshop in Belgrade\, the details of the site visits were thoroughly planned\, to ensure that patients are involved meaningfully in the process. \nQCR tool will be tested at 8 locations in 5 countries: Slovenia\, Serbia\, Croatia\, Finland and Greece.  Click here to see the description of this tool. \nThe agenda and the concept of the workshop is available here.  \nRationale\, objective and methods are described here along with the expected outcomes and recommendations in the nutshell. \nPatient involvement and patient empowerement has always been one of our focus areas as the patients are in the centre of our implementation projects. If you want to learn more on aspects and various dimentions of empowerment\, click here and learn more. \nAnd last but not least\, here you can find the Key Recommendations for Future Implementations. This presentation contains the SWOT analysis that focuses on enablers and barriers related to the implementaion. This excercise preceded the finalization of Pilot Action Plan as the essential tool for future operational planning and monitoring. \nAn important step of the implementation process is a site visit at these 8 locations during the first half of 2019 by a group of experts including the leaders of this work package. \nDuring this workshop\, the details of these site visits were planned thoroughly. The study visits were designed from a patient/person perspective to assess if the pilot activities meet patients’/persons’ expectations with a special emphasis given to the respective QCR Tool\, on empowering the target population\, as well as education and training to promote empowerment. \nValentina Strammiello\, Senior Programme Manager from  EPF commented on the event: “The WP7 Workshop was of key importance for the implementation phase of CHRODIS + project in general and specifically for the work undertaken in WP7. The objective of the Workshop was to set standardized pathways for the implementers of the QCR Tool and to prepare them to successfully run the study visits that will take place in the 5 implementing countries in 2019. Good practices and lessons learnt were shared among the stakeholders and next steps were planned.” \nFurther meetings of this working implementation group will continue in March and in April and we are happy to keep you updated! \n  \n \n 
URL:https://prescribeddrug.org/event/work-package-7-workshop-on-interim-follow-up/
LOCATION:Belgrade\, Hilton Hotel Belgrade\, Belgrade\, Serbia
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181120
DTEND;VALUE=DATE:20181122
DTSTAMP:20260418T174212
CREATED:20181126T142014Z
LAST-MODIFIED:20181127T100122Z
UID:8872-1542672000-1542844799@prescribeddrug.org
SUMMARY:SITE VISIT IN SEVILLE - Understanding the implementation of the Multimorbidity Care Model at a primary care centre
DESCRIPTION:Context: On November 20 and 21\, two important meetings were organised by CHRODIS PLUS at the Andalusian Health Service (SAS) headquarters in Seville: a workshop by Work Package 4 – Integration to National Policies and Sustainability\, and then the Executive Board meeting. After the Executive Board meeting\, members of the EB visited a primary health centre in Seville. \nSite visit to the Primary Healthcare Centre Las Palmeritas \nThe aim of the site visit to the Primary Healthcare Centre Las Palmeritas was to provide a better understanding the selected Andalusian approach for the pilot implementation within the Work Package 6 at regional level. Work Package 6 focuses on the implementation of Integrated Care Model for Multimorbidity at 5 pilot sites in Europe\, including Seville. \nThe Work Package 6 pilot implementation in Andalusia addresses component-4 (individualized care plans) of the Integrated Care Model for Multimorbidity-ICMM developed during the former Joint Action Chrodis. The general purpose of the intervention in the pilot is the assessment of the influence of the systematized application of individualized and comprehensive care plans to complex chronic patients\, within the framework of the Andalusian Public Health System strategies at primary healthcare centres. \nDuring the site visit\, first a general overview of the Andalusian Public Health System-APHS was provided by the Regional Ministry of Health of Andalusia (CSJA) project coordinator (Dr Ana Carriazo) Then the Director of the Primary Health Centre (Dr Inmaculada Gabaldón) presented how the Integrated Care Process ‘Healthcare for Multimorbidity Patients’ works in practice at the centre. She also analysed how this work is in line with the Andalusian comprehensive health plans and strategies: mainly the ‘Comprehensive Healthcare Plan for Patients with Chronic Diseases’\, the Andalusian ‘Comprehensive Care Strategy’ and the ‘Andalusian Plan for Primary Healthcare Renewal’. A fruitful debate among participants to clarify the particularities of the Andalusian model was also organised. The event ended with an on-site visit to the premises of this healthcare centre. \n \nAdditional information in Spanish: \n\nProceso Asistencial Integrado ‘Atención a pacientes pluripatológicos’ [The Integrated Care Process ‘Healthcare forMultimorbidity Patients’]\n\nhttps://juntadeandalucia.es/export/drupaljda/salud_5af1956d9925c_atencion_pacientes_pluripatologicos_2018.pdf \n\nPlan Andaluz de Atención Integrada a Pacientes con Enfermedades Crónicas – PAAIPEC [The Comprehensive Healthcare Plan for Patients with Chronic Diseases]\n\nhttps://juntadeandalucia.es/organismos/salud/areas/planificacion/plan-integral/paginas/paier.html \n\nEstrategia de Cuidados de Andalucía: nuevos retos en el cuidado de la ciudadanía – PiCuida [Andalusian Comprehensive Care Strategy].\n\nhttp://www.sas.junta-andalucia.es/contenidos/gestioncalidad/estratcuidados/estrategia_enero_2016.pdf \n\nPlan para la Renovación de la Atención Primaria en Andalucía [The Andalusian Plan for Primary Healthcare Renewal]\n\nhttp://www.sas.junta-andalucia.es/principal/documentosacc.asp?pagina=gr_renovacionap
URL:https://prescribeddrug.org/event/site-visit-in-seville-understanding-the-implementation-of-the-multimorbidity-care-model-at-a-primary-care-centre/
LOCATION:Seville\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180813
DTEND;VALUE=DATE:20180815
DTSTAMP:20260418T174212
CREATED:20180910T124626Z
LAST-MODIFIED:20181015T100907Z
UID:8743-1534118400-1534291199@prescribeddrug.org
SUMMARY:JOGG site visit in Helsinki
DESCRIPTION:The event of site visit organized under the auspices of Joint Action Chrodis+ was held on August 13-14th in Helsinki\, Finland\, hosted by THL.  The event provided a platform for deeper approach understanding of the methodology  of JOGG implementation both at local and national level. Selected elements of JOGG will be adapted and implemented within the Health Promoting Community Programme (HPC) in Iceland by the Directorate of Health. \nThe  JA-CHRODIS Good Practice “JOGG” addresses children and adolescent obesity and encourages all people in a town or neighbourhood to make healthy food and physical activity an easy and attractive lifestyle option for young people. HPC is an umbrella for comprehensive health promotion work in municipalities\, including all school levels. HPCs main aim is to support communities/schools to create supportive environments that promote healthy lifestyle\, health and well-being for all. Iceland will adapt selected elements concerning the structure of the JOGG program and the main aim of the HPC will continue to be well being for all. \nThe description of the model project is available here. \nThe objectives of this site visit were: \n\nImproved shared understanding of the JOGG approach\nExchange of good examples from the local implementation and actions from JOGG-cities\nPractical guidance on the local implementation of JOGG\nStakeholder mapping: both national and local – who to include/who do we miss?\nCommunication strategies\nAdvice on how to make contract with the local level\nHow do we support the local programme-managers – the national JOGG-support model.\nDetermine next steps on JOGG implementation
URL:https://prescribeddrug.org/event/jogg-site-visit-in-helsinki/
LOCATION:Helsinki\, Finland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20180619T133000
DTEND;TZID=Europe/Helsinki:20180619T160000
DTSTAMP:20260418T174212
CREATED:20180626T123247Z
LAST-MODIFIED:20180629T133214Z
UID:8514-1529415000-1529424000@prescribeddrug.org
SUMMARY:Site visit - mHealth tools for chronic diseases
DESCRIPTION:We had a privilage to participate at the presentation of our partner organization University of Ulm where the mHealth application is being developed and used by the patients who have developed tinnitus. \nDr. Ruediger Pryss along with Wilfried Schlee delivered a interesting and inspiring presentation on the application development as its everyday practical use. The presence of patients who are using the application underlined the added value and strengthen the importance of new technologies in the service of health. The event was a proof that mobile technologies support the achievements of health objectives. \nThe presentation is available here \nDown below you may see the photo gallery of the mHealth events as well as the pictures from Governing Board meeting. \n  \n \n  \n  \n[Best_Wordpress_Gallery id=”17″ gal_title=”All images”]\n 
URL:https://prescribeddrug.org/event/site-visit-mhealth-tools-for-chronic-diseases/
LOCATION:Ulm University\, James-Franck-Ring str.\, Ulm\, 89081\, Germany
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20180619T090000
DTEND;TZID=Europe/Helsinki:20180619T160000
DTSTAMP:20260418T174212
CREATED:20180522T145108Z
LAST-MODIFIED:20190604T083635Z
UID:8367-1529398800-1529424000@prescribeddrug.org
SUMMARY:First Governing Board Meeting
DESCRIPTION:1st Governing Board meeting of the Joint Action CHRODIS PLUS (2017-2020). \nThe purpose of the meeting: \n\ncreate a common vision\, to provide strategic guidance and thoughtful sounding board for the JA_CHRODIS PLUS\ndiscuss and agree on Terms of Reference and Operating Procedure of the Governing Board.\n\nDate: Tuesday\, 19 June 2018\, Time: 8:00 – 16:00 \nLocation: Ulm University\, James-Franck-Ring str.\, 89081 Ulm \nParticipants: one nominated person per country. See the Governing Board members list here. \nThe board session (09:00 – 14:00)  will be immediately followed by a presentation of the mHealth tool developed by the IT department of the Ulm University working for the Work Package on Fostering the Quality of Care. \n  \nClick here to see the Agenda \n1st Governing Board Meeting in Ulm – Venue \nOne-minute-video on Ulm – Click on the picture \n\nPresentations\nClick on the title of the presentation and download it!\n \n\nApproach of the CHRODIS PLUS outcomes from the decision maker perspective – Lina Jaruševičienė\, Vice Minister\, Ministry of Health of Lithuania\nEmployment and Chronic Diseases Health in All Sectors\nFostering Quality of Care for People with Chronic Diseases\nHealth Promotion and Disease Prevention\nPresentation of the proposal for the Terms of References Operating Procedures and Working Plan of the GB\nIntegration in National Policies and Sustainability\nIntegrated Care Model for Multi-morbidity\n\n\nPictures taken during the event\n[Best_Wordpress_Gallery id=”14″ gal_title=”GB Meeting ULM June 2018″]
URL:https://prescribeddrug.org/event/governing-board-in-ulm-germany/
LOCATION:Ulm University\, James-Franck-Ring str.\, Ulm\, 89081\, Germany
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20180606T133000
DTEND;TZID=Europe/Helsinki:20180607T153000
DTSTAMP:20260418T174212
CREATED:20180815T124057Z
LAST-MODIFIED:20180815T125248Z
UID:8703-1528291800-1528385400@prescribeddrug.org
SUMMARY:Active School Flag Site Visit
DESCRIPTION:The main intention behind this site visit was to demonstrate and share learning from the Active School Flag (ASF) initiative as part of  Joint Action CHRODIS-PLUS \n And what were the main learning outcomes of this site visit? \n\nTo gain an understanding of the background policy and programme context to ASF-  To gain an understanding of:\nThe key components of ASF\, in particular\, the core elements that must be implemented to achieve the desirable changes in physical activity of children\nThe ASF programme\, practical steps in engaging schools\, implementation\, administration\, etc.\nThe success criteria for participating schools\nThe different types of partnerships required to implement and support ASF\nTo learn about the success factors\, challenges and key drivers of ASF\nTo gain an insight into the research linked to ASF programme\nTo gain an understanding of ASF in practice through visiting demonstration schools across Dublin city\nTo clarify the next steps and actions required to support the pre-implementation planning phase with local implementation groups in other member states.\n\nClick here for a link to all resources and presentation from this event. \nThe full agenda of the event can be found here.
URL:https://prescribeddrug.org/event/active-school-flag-site-visit/
LOCATION:Dublin\, Ireland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20180604T080000
DTEND;TZID=Europe/Helsinki:20180605T170000
DTSTAMP:20260418T174212
CREATED:20180614T134225Z
LAST-MODIFIED:20180822T122405Z
UID:8468-1528099200-1528218000@prescribeddrug.org
SUMMARY:Pre-implementation workshop of Work Package 7 in Ljubljana
DESCRIPTION:The workshop was held on 4-5 June in order to provide the partners with pilot actions operational support for developing the Pilot Action Plan based on the Guideline for the pre–Implementation phase\, and instructions on how to use the Quality Criteria Recommendation Tool. Representatives from Task 2 (Task 2: Piloting the Quality Criteria and Recommendations Tool through pilot actions across different countries) pilot sites (Slovenia\, Croatia\, Serbia\, Greece\, and Finland) were present. \n  \nThe pilot action in Slovenia was used as a case study to verify all the necessary steps to define the  Pilot Plan. The two-day workshop mostly focused on group work in a preparatory process. At the same time\, the experience served as field training for sharing the knowledge\, skills and tools necessary for carrying out the SWOT analysis and the design of the Pilot plan within a local context. \n 
URL:https://prescribeddrug.org/event/pre-implementation-workshop-of-work-package-7-in-ljubjana/
LOCATION:Ljubljana\, Slovenia
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20180522T100000
DTEND;TZID=Europe/Helsinki:20180523T160000
DTSTAMP:20260418T174212
CREATED:20180529T154232Z
LAST-MODIFIED:20180914T142141Z
UID:8409-1526983200-1527091200@prescribeddrug.org
SUMMARY:Adaptation and implementation of the intersectoral good practices: Lombardy program "Workplace health promotion"
DESCRIPTION:Adaptation and implementation of intersectoral good practices:  Lombardy Program “Workplace Health Promotion: the WHP Lombardy network”\nThe Italian Joint Action Chrodis good practice “Lombardy Workplace Health Promotion Network” is a public-private partenrship that promotes a healthy lifestyle through different actions and information that target healthy eating\, smoking cessation\, increased physical activity\, alcohol reduction and safe walking/biking to work. \nSome elements of the Lombardy Workplace Health Promotion Network are being implemented by the Andalusian Regional Ministry of Health in Spain within CHRODIS PLUS Joint Action. \nThe description of the model is available here. \nThis good practice is part of Work Package 5 agenda. \nDate of the meeting: 22nd – 23rd May 2018\nLocation: Milano \nClick here to see the Agenda\nhttp://www.promozionesalute.regione.lombardia.it/wps/portal/site/promozione-salute \nWe are happy to share with you the Pre-implementation Phase Report  /Scope & Swot Analysis/ where you will find all that you need to know about the step-wise approach of implementation Lombardy Workplace Health Promotion by the Regional Ministry of Health of Andalusia. The report is available here. \nBrowse through our photogallery to see the pictures on the site visit\n[Best_Wordpress_Gallery id=”21″ gal_title=”Workplace Health Promotion_May 2018″]
URL:https://prescribeddrug.org/event/adaptation-and-implementation-of-the-intersectoral-good-practices-lombardy-program-workplace-health-promotion/
LOCATION:Regione Lombardia\, Piazza Citta di Lombardia 1\, Milan
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20180320T143000
DTEND;TZID=Europe/Helsinki:20180321T133000
DTSTAMP:20260418T174212
CREATED:20180215T103653Z
LAST-MODIFIED:20180613T141127Z
UID:7559-1521556200-1521639000@prescribeddrug.org
SUMMARY:WP8 Expert meeting - EMPLOYMENT AND CHRONIC CONDITIONS
DESCRIPTION:Location: Bruxelles – Fondation Universitaire\, Rue d’Egmont 11 – 1000 Brussels (Belgium) \n  \n[Best_Wordpress_Gallery id=”10″ gal_title=”WP8 – Brussels”]\nAGENDA\nTuesday 20th March 2018 h 14.30 -18.00 \n14.30 –15.00 Welcome and registration \n15.00–15.10 Presentation WP8: Employment and Chronic Diseases in Europe: linking to Pathways Recommendations \nDr. Matilde Leonardi\, Leader WP8\, FINCB \n15.10–15.35 Presentation Task 8.1 “Training tool for employers and the employment sector: CDs and employment” \nDr. Fabiola Silvaggi\, FINCB \n15.35–16.00 Presentation Task 8.2 “Toolkit for adaptation of the workplace for prevention and maintenance of chronic diseases at the workplace” \nDr. Jaana Lindstrom\, Co-leader WP8\, THL \n16.00–17.15 Presentation of some European and International “Training tools” and “Toolkits” for employment sector \nBetter inclusion of patients with chronic conditions in the workplace and training practices for employers: a European tool \nDr. Katie Gallagher\, European Patients Forum \n Cancer&Work: The French training and strategy for employers \nDr. Jérôme Foucaud\, The French National Cancer Institute \n “Not myself today”: to help employers transform mental health at work \nDr. Fred Destrebeq\, European Brain Council \n#MAKEWORKWORK: Ensuring good work for neurological patients \nDr. Donna Walsh\, European Federation of Neurological Associations \n  Work and Multiple Sclerosis: Improving workability for Multiple Sclerosis \nDr. Elisabeth Kasilingam\, European Multiple Sclerosis Platform \n17.15–17.45 Open Discussion \n17.45- 18.00 Closing of meeting by Matilde Leonardi \n  \n19.00 – 22.00  “Cocktail Dinatoire” with all partners and collaborating partners at Fondation Universitaire (at each participant’s costs) \n  \nWednesday 21st March 2018 h.9.00 -13.15 \n9.00 –10.50 Development of Chrodis+ Training tool for employers- task 8.1 \nChair: Dr. Matilde Leonardi\, Leader WP8\, FINCB \nWP8 Partners & Collaborating partners \nWork plan \nPhase 1: Literature Review and Grey Literature\, M6-M8  \nPhase 2: Structuring the training tool\, M8–M12  \nPhase 3: Training Tool in English: test pilot\, M12 – M18  \nPhase 4:Training tool translated in Italian\, French\, Slovenian\, German\, and Hungarian\, M18-M28  \nSubtask 8.1.1 Expert meeting for Multi-morbidity and Employment\, M18  \n10.50–11.10 Coffee Break  \n11.10–13.00 Development Chrodis+ Toolkit for adaptation of the workplace. Task 8.2 \nChair: Dr. Jaana Lindstrom\, Co-leader WP8\, THL \nWP8 Partners & Collaborating partners \nWork plan \nPhase 1: Literature study and website searches\, M3-M12  \nPhase 2: Interviews /focus groups with stakeholders\, M13-M15  \nPhase 3:Development of chronic disease prevention and management Toolkit in workplaces\, M15-M18  \nPhase 4: Piloting the Toolkit\, M18-M26  \nPhase 5: Reporting of the pilots and finalizing of the Toolkit\, M26-M30  \nPhase 6: Dissemination of the Toolkit M31-M36  \n13.00–13.15 Conclusions and next steps \nDr. Matilde Leonardi\, Leader WP8\, FINCB \nDr. Jaana Lindstrom\, Co-leader WP8\, THL \nExpert Meeting participants \n  \n20th-21st March 2018 \nBruxelles- Fondation Universitaire \nWP8 Leaders & Meeting secretariat:  \nMatilde Leonardi – matilde.leonardi@istituto-besta.it  \nFoundation IRCCS Neurological Institute ”Carlo Besta” (FINCB) Milan\, ITALY \nJaana Lindstrom – jaana.lindstrom@thl.fi \nNational Institute for Health and Welfare (THL)\, Helsinki\, FINLAND \nFabiola Silvaggi- fabiola.silvaggi@istituto-besta.it \nChiara Scaratti – chiara.scaratti@istituto-besta.it \nErika Guastafierro – erika.guastafierro@istituto-besta.it \nCarla Finocchiaro (Besta Grant Officer) – carla.finocchiaro@istituto-besta.it \nFoundation IRCCS Neurological Institute ”Carlo Besta” (FINCB)- Milan\, ITALY \nWP8 Partners \nLyudmil Ninov – European Patients Forum (EPF)-BELGIUM \nKatie Gallagher – European Patients Forum (EPF)-BELGIUM \nIsabelle Girard – The French National Cancer Institute (INCa)-FRANCE \nJérôme Foucaud- The French National Cancer Institute (INCa)-FRANCE \nUlf Manuwald – Technische Universität Dresden (TUD)-GERMANY \nUlrike Rothe – Technische Universität Dresden (TUD)-GERMANY \nBruno Caffari – National Institute of Health (ISS)-ITALY \nKarin Proper – National Institute for Health Public and the Environment (RIVM)-THE NETHERLAND \nJelka Zaletel – National Institute of Public Health (NIJZ)-SLOVENIA \nFrancisco Javier Dolz López – Regional Ministry of Health of Andalusia (CSJA/SAS)-SPAIN \nWP8 Collaborating Partners \nFred Destrebeq – European Brain Council (EBC) \nDonna Walsh – European Federation of Neurological Association (EFNA) \nNancy Van Hoylandt – European Federation of Neurological Association (EFNA) \nLars Munter – The Danish Committee for Health Education (ENOPE) \nOther Participants \nRogerio Ribeiro – Associação Protetora dos Diabéticos de Portugal (APDP)\, Chrodis +WP3- Evaluation \nElisabeth Kasilingam – European Multiple Sclerosis Platform (EMSP) \n  \n 
URL:https://prescribeddrug.org/event/wp8-expert-meeting/
LOCATION:Brussels – Belgium\, Mont des Arts\, Brussels\, 1000\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20180213T140000
DTEND;TZID=Europe/Helsinki:20180214T180000
DTSTAMP:20260418T174212
CREATED:20180202T110512Z
LAST-MODIFIED:20180517T102804Z
UID:7424-1518530400-1518631200@prescribeddrug.org
SUMMARY:Joint Action event in Treviso\, Italy
DESCRIPTION:[Best_Wordpress_Gallery id=”8″ gal_title=”Treviso”]\nMeeting venue: Centro  Studi Achille e Linda Lorenzen –  Catholic University of the Sacred Heart\, Treviso\, Italy \nDate: February 13-14\, 2018\n\n\n\n\n\n\n\n\n  \n  \n\nImplementation workshop\nFebruary 13th  2018 (starting at 2 p.m.) and February 14th (ending at 1 p.m.) \nWorkshop aims to define the common methodology and process for the cross-national implementation pilots \nAgenda\nFebruary 13th 2018\n14:00 – 14:30 Opening session \n14:30 – 15:00 Presentation of the implementation strategy \n15:00 – 15:30 Pre-implementation phase: Techniques and working plan \n15:30 – 17:30 Working groups’ session \n17:30 – 18:30 Plenary session \n18:30 – 18:45 Wrap up \nFebruary 14th 2018\n9:00 – 09:15 Presentation of the day \n9:15 – 9:45    Collaborative methodology \n9:45 – 11:45   Working groups’ session \n11:45 – 12:45 Plenary session \n 12:45 – 13:00 Wrap up and future work \n13:00 – 13:15 Work Package 3 – Protocol requirements \n  \nWork Package 4 workshop\nFebruary 14th 2018 (starting at 2 p.m.) lasting all afternoon \nWorkshop aims to discuss the key principles to create a common vision regarding the post 2020 perspective: integration in national policies\, sustainability and EU added value \nAgenda\n15:00 – 15.15 Introduction (I. Imaz)  \n15.15 – 15.45 Presentation of the concepts: Integration in National policies\, Sustainability\, EU added value (Giovanni Nicoletti\, P. Michelutti) \n15.45 – 17.00 Work in 4 parallel groups (15+60 min) Moderator: J. Zaletel \n \n Group 1– Facilitator: C. Marinetti\, G. Nicoletti \n15.45 – 16.00 Presentation of an example of the good practice in health promotion \n16.00 – 17.00 Discussion session \n  \nGroup 2– Facilitator: G. Onder\, R. Navickas\, P. Michelutti \n15.45 – 16.00 Presentation of IMM care model \n16.00 – 17.00 Discussion session \n  \nGroup 3– Facilitator: M. Maggini\, A Giusti \n15.45 – 16.00 Presentation of QCR Tool \n16.00 – 17.00 Discussion session \n  \nGroup 4– Facilitator: M. Leonardi\, J. Lindstrom \n15.45 – 16.00 presentation of an example of the good practice in employment area \n16.00 – 17.00 Discussion session \n  \n17.00 – 17:45 Reporting back by group facilitators \n17.45 – 18.00 Closing remarks – (P. Michelutti\, J. Zaletel) \n 
URL:https://prescribeddrug.org/event/project-event-treviso-italy/
LOCATION:Treviso\, Treviso\, Italy
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170918
DTEND;VALUE=DATE:20170921
DTSTAMP:20260418T174212
CREATED:20171123T205941Z
LAST-MODIFIED:20190511T105741Z
UID:6974-1505692800-1505951999@prescribeddrug.org
SUMMARY:CHRODIS PLUS Joint Action Kick-Off Meeting
DESCRIPTION:AGENDA \n  \nMonday 18 September 2017 \nPublic session at the Artis Centrum hotel Totoriu str. 23\, 01120\, Vilnius\, Lithuania \n9:00 – 10:00 –     Official opening session \n– Minister of Health\, Lithuania\, Aurelijus Veryga \n– European Commissioner for Health\, Vytenis Andriukaitis\nThe Commissioner Andriukaitis gave a video interview on the importance of CHRODIS PLUS. Click here to download the video.\nTo read the speech of Vytenis Andriukaitis\, please\, click here. \n10:00 – 10:30 –   Keynote speech Dr. Miklos Szocska\, former Minister of State for Health of  Hungary \n10:30 – 11:00 –   Presentation of the new joint action by the coordinator Antonio Sarria Santamera and the scientific coordinator Rokas Navickas \n11:00 – 11:30 –   End of the public session with a coffee break \n11:00 – 11:30 –   Press conference / options for press contact with Commissioner   V.Andriukaitis\, representative of the Lithuanian Ministry of Health and Dr. G. Galea \n11:30 – 12:15 –   Administrative aspects of joint action management – Marc Vandenbroeck\, Chafea \n12:15 – 13:15 –   Lunch break \n13:15 – 14:00 –   Financial aspects of joint action management – Klara Kasnyik\, Chafea \n14:00 – 15:00 –   Questions and answers \n15:00 – 15:30 –   Coffee break \n15:30 – 17:00 –   Presentation of the horizontal work packages by the (co-)coordinators – Work Package 1\, Work Package 2 and Work Package 3 \n  \nTuesday 19 September 2017 \n9:00 – 9:15 –     Introduction to the CHRODIS PLUS kick-off meeting – A. Sarria Santamerra \n9:15 – 10:30 –   Presentation of each core work package (Work Package 4\,  Work Package 5\, Work Package 6\, Work Package 7 and Work Package 8) by the (co-) coordinators \n10:30 – 11:00 –   Coffee break \n11:00 – 13:00 –   Working groups according to the work packages \n13:00 – 14:00 –   Networking lunch \n14:00 – 17:30 –   Working groups continued (coffee break to be taken by the groups) \n18.30 – 19.20 –   Group discussion on common methodology (piloting) in WP5\, WP6  and WP7 (Lead by KRONIGUNE with WP 5\,6\,7 leaders and co-leaders) \n  \n Wednesday 20 September 2017 \n8:15 – 9:15   –    Reporting back from the working groups: WP4\, WP5\, WP6\, WP7 and WP8 \n9:15 – 11:15  –    Presentation and discussion on horizontal issues concerning various the partners: \n– commonalities of the transfer/piloting methodology in WP5\, WP6\, WP7 (Methodology presentation by KRONIGUE) \n– the policy dialogues (EHNet) \n– organization of dissemination activities\, GB and EB meetings\, site visits and other events with a maximum benefit and communication impact (WP2) \n[Best_Wordpress_Gallery id=”33″ gal_title=”Vilnius”]
URL:https://prescribeddrug.org/event/chrodis-plus-joint-action-kick-off-meeting/
LOCATION:Vilnius – Lithuania\, Vilnius\, Lithuania
END:VEVENT
END:VCALENDAR